Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ENDO PHARMACEUTICALS HOLDINGS INC | 48,866 | reported | 21 Feb 2008 | tx 3+130,565 |
| Viking Therapeutics, Inc. | 33,150 | reported | 02 Jan 2026 | tx 22+370,350−200,000 |
| Nabriva Therapeutics AG | 15,277 | reported | 01 Aug 2022 | tx 11+242,100−9,273 |
| Nabriva Therapeutics Plc | 10,100 | reported | 23 Jun 2017 | tx 2+26,100 |
| Blueprint Medicines Corp | 4,500 | reported | 02 Jun 2021 | tx 27+83,044−66,766 |
| IDENIX PHARMACEUTICALS INC | 0 | reported | 05 Aug 2014 | tx 6+60,000−60,000 |
| BIND Therapeutics, Inc | 0 | reported | 26 Aug 2016 | tx 5+70,000−15,000 |
| Orchard Therapeutics plc | 0 | reported | 24 Jan 2024 | tx 7+226,000−163,294 |
| Generation Bio Co. | 0 | reported | 09 Feb 2026 | tx 25+735,957−167,264 |
| VIROPHARMA INC | 0 | reported | 24 Jan 2014 | tx 70+851,411−859,247 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Feb 2026 | TENDER | Generation Bio Co. | 53,475 | — | |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 3,000 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 4,246 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 5,200 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 6,000 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 1,920 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 2,500 | — | deriv |
| 09 Feb 2026 | OTHER | Generation Bio Co. | 1,500 | — | deriv |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 3,150 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 20,400 | 0.00 USD | deriv |
| 27 Oct 2025 | SALE | Viking Therapeutics, Inc. | 60,000 | 35.57 USD | |
| 27 Oct 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 22,000 | 4.88 USD | |
| 27 Oct 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 22,000 | 5.80 USD | |
| 27 Oct 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 16,000 | 4.48 USD | |
| 27 Oct 2025 | EXERCISE | Viking Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 27 Oct 2025 | EXERCISE | Viking Therapeutics, Inc. | 22,000 | 0.00 USD | deriv |
| 27 Oct 2025 | EXERCISE | Viking Therapeutics, Inc. | 16,000 | 0.00 USD | deriv |
| 04 Jun 2025 | GRANT_AWARD | Generation Bio Co. | 30,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 18,800 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Generation Bio Co. | 60,000 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 12,294 | — | |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 46,000 | 0.00 USD | deriv |
| 24 Jan 2024 | OTHER | Orchard Therapeutics plc | 105,000 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Viking Therapeutics, Inc. | 32,000 | 0.00 USD | deriv |
| 04 Dec 2023 | PURCHASE | Generation Bio Co. | 150,000 | 1.50 USD |
4 purchases reported after at least 12 months of silence — most recent on 01 Dec 2023.